NASDAQ:VKTX | Insider Transactions — Page 2 | Viking Therapeutics, Inc.

VKTX Insider Transactions — Page 2

124 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–124; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
ZANTE GREGChief Financial Officer2023-04-11Sale56,295.0$18.0
Lian BrianPresident & CEO2023-04-03Sale22,000.0$17.85
ZANTE GREGChief Financial Officer2023-04-03Sale30,911.0$18.0
Lian BrianPresident & CEO2023-03-31Sale67,970.0$17.45
Lian BrianPresident & CEO2023-03-30Sale65,382.0$17.45
Lian BrianPresident & CEO2023-03-30Sale88,000.0$16.95
ZANTE GREGChief Financial Officer2023-03-30Sale131,029.0$17.0
Mancini MariannaChief Operating Officer2023-03-29Sale41,242.0$16.0
Mancini MariannaChief Operating Officer2023-03-28Sale196,563.0$15.0
FOEHR MATTHEW WDirector2022-05-02Purchase45,000.0$2.47
FOEHR MATTHEW WDirector2021-06-10Purchase20,000.0$5.69
LIGAND PHARMACEUTICALS INCTenPercentOwner2020-08-26Sale148,700.0$8.11
LIGAND PHARMACEUTICALS INCTenPercentOwner2020-08-26Sale94,488.0$8.11
LIGAND PHARMACEUTICALS INCTenPercentOwner2020-08-25Sale70,000.0$8.02
FOEHR MATTHEW WDirector2020-06-30Sale13,000.0$7.35
LIGAND PHARMACEUTICALS INCTenPercentOwner2018-09-25Sale262,881.0$19.15
SINGLETON J MATTHEWDirector2018-05-31Purchase9,500.0$9.82
MORNEAU MICHAELVP, Finance and Administration2018-05-31Sale21,551.0$9.25
Rowland Charles A JrDirector2018-05-29Purchase30,000.0$5.16
Webster Stephen WDirector2018-05-29Purchase8,000.0$5.21
MACARTNEY LAWSONDirector2018-05-29Purchase47,965.0$5.22
FOEHR MATTHEW WDirector2016-11-15Purchase13,000.0$1.21
FOEHR MATTHEW WDirector2016-04-13Purchase20,000.0$1.24
FOEHR MATTHEW WDirector2015-05-04Purchase6,250.0$8.0